Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Major study to directly compare PEG-Intron and Pegasys for HCV

Sep. 30, 2003

Boehringer Ingelheim presents new HCV NS3 inhibitors

Sep. 30, 2003

Phase III hepatitis C trial of Zadaxin enrolled

Sep. 29, 2003

FDA grants orphan drug designation for IDN-6556 in liver transplantation

Sep. 29, 2003

Adolor announces positive results in phase III alvimopan study for postoperative ileus

Sep. 29, 2003

DanioLabs and Oxagen enter collaborative agreement for IBD

Sep. 23, 2003

New 5-HT2B antagonists and their use in GI disorders described by Pharmagene

Sep. 23, 2003

Eisai submits E.U. Pariet application for on-demand therapy of symptomatic GERD

Sep. 22, 2003

New tripeptides with HCV NS3-inhibitory activity covered by Boehringer Ingelheim patent

Sep. 19, 2003

Early response to antivirals predicts sustained response in chronic hepatitis C

Sep. 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...